Mabylon develops therapeutic human antibodies to treat neurological disorders and severe allergies. Technology allows screening large numbers of sera and rapidly discovering extremely rare target-specifc antibodies. It also provides information on activity in human for effective and safe products.


Wagistrasse 14, 8952 Schlieren, Switzerland

Facts & figures
  • Type of organization
    Private company
  • Year of foundation
  • Number of employees in Switzerland
Key business